WELLS FARGO & COMPANY/MN - COEPTIS THERAPEUTICS HLDGS I ownership

COEPTIS THERAPEUTICS HLDGS I's ticker is and the CUSIP is 19207A108. A total of 12 filers reported holding COEPTIS THERAPEUTICS HLDGS I in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
WELLS FARGO & COMPANY/MN ownership history of COEPTIS THERAPEUTICS HLDGS I
ValueSharesWeighting
Q3 2023$125
+13.6%
108
+52.1%
0.00%
Q2 2023$110
+17.0%
71
+9.2%
0.00%
Q1 2023$94
-4.1%
65
+1.6%
0.00%
Q4 2022$98640.00%
Other shareholders
COEPTIS THERAPEUTICS HLDGS I shareholders Q1 2023
NameSharesValueWeighting ↓
Antara Capital LP 45,000$64,4760.00%
Virtu Financial LLC 16,216$230.00%
OSAIC HOLDINGS, INC. 67$960.00%
WELLS FARGO & COMPANY/MN 65$940.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 39,593$57,0130.00%
WOLVERINE ASSET MANAGEMENT LLC 222$3190.00%
Cambridge Investment Research Advisors, Inc. 64,749$930.00%
Tower Research Capital LLC (TRC) 4,935$70.00%
BARCLAYS PLC 67$00.00%
View complete list of COEPTIS THERAPEUTICS HLDGS I shareholders